These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26780675)

  • 21. Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes.
    Yue L; Feng JL; Wang Z; Nattel S
    Cardiovasc Res; 2000 Apr; 46(1):151-61. PubMed ID: 10727663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of pharmacokinetic-pharmacodynamic analysis for detecting small magnitudes of QTc prolongation in preclinical safety testing.
    Gotta V; Cools F; van Ammel K; Gallacher DJ; Visser SA; Sannajust F; Morissette P; Danhof M; van der Graaf PH
    J Pharmacol Toxicol Methods; 2015; 72():1-10. PubMed ID: 25556117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
    Salerno DM; Hodges M; Granrud G; Sharkey P
    Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds.
    Wallman M; Borghardt JM; Martel E; Pairet N; Markert M; Jirstrand M
    J Pharmacol Toxicol Methods; 2022; 115():107171. PubMed ID: 35398273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translating QT interval prolongation from conscious dogs to humans.
    Dubois VF; Smania G; Yu H; Graf R; Chain AS; Danhof M; Della Pasqua O; ;
    Br J Clin Pharmacol; 2017 Feb; 83(2):349-362. PubMed ID: 27614058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.
    Gotta V; Cools F; van Ammel K; Gallacher DJ; Visser SA; Sannajust F; Morissette P; Danhof M; van der Graaf PH
    Br J Pharmacol; 2015 Sep; 172(17):4364-79. PubMed ID: 26076100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram.
    Morganroth J; Horowitz LN
    Am J Cardiol; 1984 Feb; 53(5):89B-94B. PubMed ID: 6695821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational pharmacokinetic-pharmacodynamic modeling of QTc effects in dog and human.
    Parkinson J; Visser SA; Jarvis P; Pollard C; Valentin JP; Yates JW; Ewart L
    J Pharmacol Toxicol Methods; 2013; 68(3):357-66. PubMed ID: 23567074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.
    Chui RW; Fosdick A; Conner R; Jiang J; Bruenner BA; Vargas HM
    J Pharmacol Toxicol Methods; 2009; 60(1):58-68. PubMed ID: 19426820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine.
    El-Eraky H; Thomas SH
    Br J Clin Pharmacol; 2003 Aug; 56(2):198-204. PubMed ID: 12895193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The proarrhythmic effects of flecainide.
    Nathan AW; Hellestrand KJ; Bexton RS; Spurrell RA; Camm AJ
    Drugs; 1985; 29 Suppl 4():45-53. PubMed ID: 4006779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.
    Chaves AA; Zingaro GJ; Yordy MA; Bustard KA; O'Sullivan S; Galijatovic-Idrizbegovic A; Schuck H; Christian DB; Hoe CM; Briscoe RJ
    J Pharmacol Toxicol Methods; 2007; 56(2):103-14. PubMed ID: 17643323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
    Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome.
    Stokoe KS; Balasubramaniam R; Goddard CA; Colledge WH; Grace AA; Huang CL
    J Physiol; 2007 May; 581(Pt 1):255-75. PubMed ID: 17303635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical application of guinea pig telemetry system for QT evaluation.
    Shiotani M; Harada T; Abe J; Sawada Y; Hashimoto K; Hamada Y; Horii I
    J Toxicol Sci; 2005 Aug; 30(3):239-47. PubMed ID: 16141657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
    Brembilla-Perrot B; Terrier de la Chaise A; Jacquemin L; Beurrier D; Houplon P; Louis P; Danchin N
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):961-6. PubMed ID: 9339257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.